Approval · Notice of Compliance 4278 · 1996
TRIPACEL: Notice of Compliance 4278
Issued July 10, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4278
- Date
- July 10, 1996
- Company
- Connaught Laboratories Ltd.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRIPACEL | 02224143 | Cancelled Post Market |
Medicinal ingredients
- DIPHTHERIA TOXOID 15 LF per 0.5ML
- TETANUS TOXOID 5 LF per 0.5ML
- PERTUSSIS TOXOID 20 MCG per 0.5ML
- FILAMENTOUS HAEMAGGLUTININ 20 MCG per 0.5ML
- PERTACTIN 3 MCG per 0.5ML
- FIMBRIAE 5 MCG per 0.5ML